12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Sigilon Therapeutics (NASDAQ:SGTX) stock rose 15.5% to $1.49 during Monday's after-market session. The market value of their outstanding shares is at $48.1 million.
50 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87.
Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday.
Esperion Therapeutics Q4 EPS $(1.77) Beats $(2.27) Estimate, Sales $15.40M Beat $14.47M Estimate
Esperion Therapeutics (NASDAQ:ESPR) reported quarterly losses of $(1.77) per share which beat the analyst consensus estimate of $(2.27) by 22.03 percent. This is a 54.5 percent increase over losses of $(3.89) per share
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell
• Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million.
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Credit Suisse Maintains Neutral on Esperion Therapeutics, Lowers Price Target to $6
Credit Suisse analyst Judah Frommer maintains Esperion Therapeutics (NASDAQ:ESPR) with a Neutral and lowers the price target from $8 to $6.